# Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome

> **NCT05305677** · NA · COMPLETED · sponsor: **Peking University Third Hospital** · enrollment: 88 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** NMN intervention
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05305677
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305677, "Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05305677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*